Exome Sequencing Identified Susceptible Genes for High Residual Risks in Early‐Onset Coronary Atherosclerotic Disease

Runda Wu,Ya Su,Jianquan Liao,Juan Shen,Yuanji Ma,Wei Gao,Zheng Dong,Yuxiang Dai,Kang Yao,Junbo Ge
DOI: https://doi.org/10.1002/clc.70066
2024-12-15
Clinical Cardiology
Abstract:Whole exome sequencing were conducted in EOCAD patients without defined conventional risk factors and CAD‐free control subjects. The sequenced nonsynonymous single nucleotide variants were subjected to variant annotation and gene mapping with disease‐related database. Finally, six novel susceptible genes associated with residual risks for EOCAD were acquired by clinical phenotype analysis. Aims Despite the tremendous improvement in therapeutic medication and intervention for coronary atherosclerotic disease (CAD), residual risks remain. Exome sequencing enables identification of rare variants and susceptibility genes for residual risks of early‐onset coronary atherosclerotic disease (EOCAD) with well‐controlled conventional risk factors. Methods We performed whole‐exome sequencing of subjects who had no conventional risk factors, defined as higher body mass index, smoking, hypertension and dyslipidemia, screened from 1950 patients with EOCAD (age ≤ 45 years, at least 50% stenosis of coronary artery by angiography), and selected control subjects from 1006 elder (age ≥ 65 years) with
cardiac & cardiovascular systems
What problem does this paper attempt to address?